clinical-data
(5)
David Lazerson
David Lazerson is the co-founder and CEO of Briya, a healthcare technology company that connects hospitals, research institutions, and life sciences organizations so they can share de-identified, real-world patient data securely and in compliance with U.S. and European privacy rules. A physicist and cognitive scientist by training and a former Israeli military cyber operations officer, Lazerson built Briya on cryptography, federated learning, and zero-knowledge proofs, and in 2025 launched Briya AIRE, a clinical-grade AI research assistant that lets researchers ask questions in plain language instead of writing code.
Nishant Hari
Nishant Hari is the founder and CEO of Predoc, a New York-based AI-native platform for health information management that retrieves, structures, and analyzes patient medical records for hospitals, oncology practices, and clinical trials. In September 2025 the company disclosed $30 million in combined seed and Series A funding led by Base10 Partners, with Northzone, Eniac, ERA, and angel investors from Flatiron Health, Datavant, Thirty Madison and Blackstone. Predoc reports 700% year-over-year revenue growth and cuts record retrieval times by up to 75% for customers like The Oncology Institute.
Vish Srivastava
Vish Srivastava is the co-founder and CEO of Century Health, a New York based AI company turning the messy, unstructured clinical notes buried inside electronic health records into structured, analyzable real-world evidence. Century's abstraction engine, CHARM, reads doctors' notes and pathology reports and pulls out clinical variables with 97% validated accuracy while keeping traceability back to the source document. The company focuses on therapeutic areas like gastroenterology, neurology, and rheumatology, and raised an oversubscribed $5M seed round in May 2026 led by Origin Ventures. Srivastava's pitch is simple and stubborn: the data needed to accelerate medical breakthroughs has already been collected during patient care; it just needs to be made accessible and actionable.
Anthony Costello
Anthony Costello is the CEO of Medidata Solutions, a Dassault Systèmes company, and one of clinical research technology's most seasoned architects. With nearly 30 years in the field, he started as a data manager at Genentech, co-founded two companies (Nextrials and Mytrus), and was acquired by Medidata before rising to lead it. Today he oversees over 8,000 active clinical studies globally each year, championing AI-driven trial innovation, decentralized models, and patient-centric design at the White House Clinical Trials Forum and beyond.
Brent Dover
Brent Dover is the CEO of Carta Healthcare, an AI-powered clinical data management platform that serves hospitals and health systems nationwide using a 'Hybrid Intelligence' model combining AI with human expert abstractors. With over 20 years of healthcare technology leadership, Dover has presided over company-defining exits and growth events - including leading Medicity to a $500M acquisition by Aetna generating 16x investor returns, scaling Health Catalyst toward a NASDAQ IPO, and growing Commure to a $3.5B valuation. He joined Carta Healthcare in December 2023 and has since driven 2x revenue growth, 100% customer retention, and a $18.25M Series B1 round led by UPMC Enterprises.